Medscape's 2018 Ethics Report unveils doctors' opinions on money, romance with patients, and their most trying ethical dilemmas.

John O'Brien, a former executive at CareFirst Blue Cross Blue Shield, will oversee the Trump administration's implementation of a proposed Medicare Part B drug pricing model intended to bring provider reimbursements in line with prices paid in other countries.

CMS actuaries say U.S. health care spending increased by 3.9% to $3.5 trillion in 2017, down from a growth rate of 4.3% in 2016.

CVS Health starting Jan. 1, 2019, will offer a new prescription benefit option that will pass on 100% of any discounts or rebates offered by drugmakers to clients that adopt the model.

HHS, the Department of Labor, and the Department of the Treasury in a 119-page report recommend reforms across the U.S. health care market to promote choice and competition.

Sens. Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.), the incoming leaders of the Senate Finance Committee, released a draft bill that would provide HHS with the authority to penalize drugmakers participating in the Medicaid Drug Rebate Program for misclassifying their products.

Hedda Martin, a 60-year-old Michigan resident who needs a heart transplant, was denied the procedure and told to raise $10,000 before providers would consider the transplant—and her viral social media post has shed a light on how cost can be a barrier to patients in need of new organs.

A number of health systems, cancer centers, and other providers are coming together to form networks intended to make it easier for pharmaceutical companies to use their facilities—and patients—to conduct clinical trials.

CMS Administrator Seema Verma detailed four ways states could use revamped federal waivers to skirt requirements under the Affordable Care Act, drawing criticism from Democrats and some policy experts who say the recommendations could violate the law.

HHS has finalized a long-delayed ceiling price and civil monetary penalties rule for Medicare's 340B drug discount program that is slated to take effect Jan. 1, 2019.